Publications: Michelle Monje-Deisseroth

← Back to Author Profile

  • Affiliation: Professor of Neurology, Howard Hughes Medical Institute Investigator, Stanford University
  • Author ID: Uwn-5VMAAAAJ
  • Cited publications: 182

Download CSV for Michelle Monje-Deisseroth

Title Year Citations Score
An integrative model of cellular states, plasticity, and genetics for glioblastoma
Cell 178 (4), 835-849. e21, 2019
View on Google Scholar ↗
2019 1543 99.6%
Inflammatory blockade restores adult hippocampal neurogenesis
Science 302 (5651), 1760-1765, 2003
View on Google Scholar ↗
2003 2807 99.3%
Microglia states and nomenclature: A field at its crossroads
Neuron 110 (21), 3458-3483, 2022
View on Google Scholar ↗
2022 438 99.2%
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
Nature 603 (7903), 934-941, 2022
View on Google Scholar ↗
2022 351 99.0%
Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain
Science 344 (6183), 1252304, 2014
View on Google Scholar ↗
2014 1246 98.9%
Electrical and synaptic integration of glioma into neural circuits
Nature 573 (7775), 539-545, 2019
View on Google Scholar ↗
2019 764 98.8%
Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma
Nature 539 (7628), 309-313, 2016
View on Google Scholar ↗
2016 943 98.5%
Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation
Cell 185 (14), 2452-2468. e16, 2022
View on Google Scholar ↗
2022 252 98.4%
Distinguishing features of Long COVID identified through immune profiling
Nature 623 (7985), 139-148, 2023
View on Google Scholar ↗
2023 185 98.4%
Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq
Science 355 (6332), eaai8478, 2017
View on Google Scholar ↗
2017 821 98.3%
Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma
Cancer cell 32 (4), 520-537. e5, 2017
View on Google Scholar ↗
2017 817 98.3%
Irradiation induces neural precursor-cell dysfunction
Nature medicine 8 (9), 955-962, 2002
View on Google Scholar ↗
2002 1420 98.1%
c-Jun overexpression in CAR T cells induces exhaustion resistance
Nature 576 (7786), 293-300, 2019
View on Google Scholar ↗
2019 535 98.0%
Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas
Cancer cell 24 (5), 660-672, 2013
View on Google Scholar ↗
2013 721 97.5%
Neuronal activity promotes glioma growth through neuroligin-3 secretion
Cell 161 (4), 803-816, 2015
View on Google Scholar ↗
2015 639 97.5%
CAR T cells targeting B7-H3, a pan-cancer antigen, demonstrate potent preclinical activity against pediatric solid tumors and brain tumors
Clinical Cancer Research 25 (8), 2560-2574, 2019
View on Google Scholar ↗
2019 413 97.3%
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
Nature medicine 21 (6), 555-559, 2015
View on Google Scholar ↗
2015 604 97.3%
Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq
Science 360 (6386), 331-335, 2018
View on Google Scholar ↗
2018 516 97.2%
The neurobiology of long COVID
Neuron 110 (21), 3484-3496, 2022
View on Google Scholar ↗
2022 132 96.5%
Disruption of oligodendrogenesis impairs memory consolidation in adult mice
Neuron 105 (1), 150-164. e6, 2020
View on Google Scholar ↗
2020 282 96.4%
Excitation-neurogenesis coupling in adult neural stem/progenitor cells
Neuron 42 (4), 535-552, 2004
View on Google Scholar ↗
2004 826 96.4%
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
Nature genetics 46 (5), 457-461, 2014
View on Google Scholar ↗
2014 498 96.3%
Extreme sensitivity of adult neurogenesis to low doses of X-irradiation
Cancer research 63 (14), 4021-4027, 2003
View on Google Scholar ↗
2003 803 96.0%
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
Nature medicine 24 (5), 572-579, 2018
View on Google Scholar ↗
2018 378 95.9%
Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma
Nature 549 (7673), 533-537, 2017
View on Google Scholar ↗
2017 390 95.7%
Pediatric high-grade glioma: biologically and clinically in need of new thinking
Neuro-oncology 19 (2), 153-161, 2017
View on Google Scholar ↗
2017 356 95.2%
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
Science translational medicine 9 (381), eaaf2968, 2017
View on Google Scholar ↗
2017 345 95.1%
Roadmap for the emerging field of cancer neuroscience
Cell 181 (2), 219-222, 2020
View on Google Scholar ↗
2020 215 95.1%
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication
Nature medicine 28 (2), 333-344, 2022
View on Google Scholar ↗
2022 98 95.0%
Methotrexate chemotherapy induces persistent tri-glial dysregulation that underlies chemotherapy-related cognitive impairment
Cell 176 (1), 43-55. e13, 2019
View on Google Scholar ↗
2019 247 94.9%
Transcriptional dependencies in diffuse intrinsic pontine glioma
Cancer cell 31 (5), 635-652. e6, 2017
View on Google Scholar ↗
2017 312 94.5%
Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors
Nature medicine 26 (5), 712-719, 2020
View on Google Scholar ↗
2020 190 94.3%
Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain
BioRxiv, 2022
View on Google Scholar ↗
2022 84 94.0%
Glioblastoma remodelling of human neural circuits decreases survival
Nature, 1-9, 2023
View on Google Scholar ↗
2023 52 93.5%
Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
Nature medicine 20 (7), 732-740, 2014
View on Google Scholar ↗
2014 315 93.4%
Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy
The oncologist 13 (12), 1285-1295, 2008
View on Google Scholar ↗
2008 395 92.7%
Loss of adaptive myelination contributes to methotrexate chemotherapy-related cognitive impairment
Neuron 103 (2), 250-265. e8, 2019
View on Google Scholar ↗
2019 180 92.6%
Radiation injury and neurogenesis
Current opinion in neurology 16 (2), 129-134, 2003
View on Google Scholar ↗
2003 469 92.3%
Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma
Proceedings of the National Academy of Sciences 108 (11), 4453-4458, 2011
View on Google Scholar ↗
2011 321 91.8%
NF1 mutation drives neuronal activity-dependent initiation of optic glioma
Nature 594 (7862), 277-282, 2021
View on Google Scholar ↗
2021 95 91.3%
Cancer neuroscience: State of the field, emerging directions
Cell 186 (8), 1689-1707, 2023
View on Google Scholar ↗
2023 38 91.0%
Developmental origins and emerging therapeutic opportunities for childhood cancer
Nature medicine 25 (3), 367-376, 2019
View on Google Scholar ↗
2019 148 90.7%
Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies
Annals of Neurology: Official Journal of the American Neurological …, 2007
View on Google Scholar ↗
2007 329 90.7%
Myelin plasticity and nervous system function
Annual review of neuroscience 41, 61-76, 2018
View on Google Scholar ↗
2018 181 90.6%
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening
Science translational medicine 11 (519), eaaw0064, 2019
View on Google Scholar ↗
2019 143 90.4%
Wrapped to adapt: experience-dependent myelination
Neuron 95 (4), 743-756, 2017
View on Google Scholar ↗
2017 187 90.3%
Neural precursor-derived pleiotrophin mediates subventricular zone invasion by glioma
Cell 170 (5), 845-859. e19, 2017
View on Google Scholar ↗
2017 185 90.1%
Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis
Behavioural brain research 227 (2), 376-379, 2012
View on Google Scholar ↗
2012 244 89.6%
Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells
Nature medicine 24 (8), 1204-1215, 2018
View on Google Scholar ↗
2018 163 89.5%
Histone variant and cell context determine H3K27M reprogramming of the enhancer landscape and oncogenic state
Molecular cell 76 (6), 965-980. e12, 2019
View on Google Scholar ↗
2019 124 88.8%
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
Nature communications 10 (1), 2235, 2019
View on Google Scholar ↗
2019 117 88.0%
Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma
Acta neuropathologica communications 6, 1-12, 2018
View on Google Scholar ↗
2018 139 87.6%
The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location
Nature Genetics 54 (12), 1881-1894, 2022
View on Google Scholar ↗
2022 44 87.5%
Microglia in cancer therapy-related cognitive impairment
Trends in neurosciences 44 (6), 441-451, 2021
View on Google Scholar ↗
2021 61 85.8%
Cancer hallmarks intersect with neuroscience in the tumor microenvironment
Cancer cell 41 (3), 573-580, 2023
View on Google Scholar ↗
2023 24 85.6%
CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma
Genome biology 21 (1), 1-18, 2020
View on Google Scholar ↗
2020 82 85.4%
Maladaptive myelination promotes generalized epilepsy progression
Nature neuroscience 25 (5), 596-606, 2022
View on Google Scholar ↗
2022 34 83.6%
Diffuse intrinsic pontine glioma: from diagnosis to next-generation clinical trials
Current treatment options in neurology 21, 1-11, 2019
View on Google Scholar ↗
2019 83 83.0%
Remote neuronal activity drives glioma progression through SEMA4F
Nature 619 (7971), 844-850, 2023
View on Google Scholar ↗
2023 20 82.8%
The neuroscience of cancer
Nature 618 (7965), 467-479, 2023
View on Google Scholar ↗
2023 20 82.8%
Contemporary survival endpoints: an international diffuse intrinsic pontine glioma registry study
Neuro-oncology 19 (9), 1279-1280, 2017
View on Google Scholar ↗
2017 109 82.8%
Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1
Nature communications 13 (1), 2785, 2022
View on Google Scholar ↗
2022 32 82.5%
ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma
Communications biology 2 (1), 156, 2019
View on Google Scholar ↗
2019 80 82.4%
Myelin plasticity in the central nervous system
Neuropharmacology 110, 563-573, 2016
View on Google Scholar ↗
2016 114 82.3%
Activity shapes neural circuit form and function: a historical perspective
Journal of Neuroscience 40 (5), 944-954, 2020
View on Google Scholar ↗
2020 65 81.6%
Tumor inflammation-associated neurotoxicity
Nature Medicine 29 (4), 803-810, 2023
View on Google Scholar ↗
2023 18 81.1%
Glioma synapses recruit mechanisms of adaptive plasticity
Nature 623 (7986), 366-374, 2023
View on Google Scholar ↗
2023 18 81.1%
Diffuse intrinsic pontine glioma: new pathophysiological insights and emerging therapeutic targets
Current Neuropharmacology 15 (1), 88-97, 2017
View on Google Scholar ↗
2017 97 80.7%
Neuronal activity in ontogeny and oncology
Trends in cancer 3 (2), 89-112, 2017
View on Google Scholar ↗
2017 85 78.2%
Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1
Nature cancer 3 (8), 976-993, 2022
View on Google Scholar ↗
2022 25 78.0%
Cranial radiation therapy and damage to hippocampal neurogenesis
Developmental disabilities research reviews 14 (3), 238-242, 2008
View on Google Scholar ↗
2008 136 77.9%
Bad wrap: Myelin and myelin plasticity in health and disease
Developmental neurobiology 78 (2), 123-135, 2018
View on Google Scholar ↗
2018 74 77.3%
Defining microglial states and nomenclature: a roadmap to 2030
View on Google Scholar ↗
2022 24 77.2%
Diffuse intrinsic pontine glioma: molecular landscape and emerging therapeutic targets
Current opinion in oncology 31 (6), 522, 2019
View on Google Scholar ↗
2019 59 76.4%
Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma
Neuro-oncology 22 (9), 1302-1314, 2020
View on Google Scholar ↗
2020 47 75.0%
Subventricular spread of diffuse intrinsic pontine glioma
Acta neuropathologica 128, 605-607, 2014
View on Google Scholar ↗
2014 91 75.0%
Senescence induced by BMI1 inhibition is a therapeutic vulnerability in H3K27M-mutant DIPG
Cell reports 33 (3), 2020
View on Google Scholar ↗
2020 44 73.6%
BAF complex maintains glioma stem cells in pediatric H3K27M glioma
Cancer discovery 12 (12), 2880-2905, 2022
View on Google Scholar ↗
2022 20 73.4%
Monosynaptic tracing maps brain-wide afferent oligodendrocyte precursor cell connectivity
Elife 8, e49291, 2019
View on Google Scholar ↗
2019 49 72.2%
An active role for neurons in glioma progression: making sense of Scherer’s structures
Neuro-oncology 20 (10), 1292-1299, 2018
View on Google Scholar ↗
2018 56 71.3%
Functional and structural differences in the hippocampus associated with memory deficits in adult survivors of acute lymphoblastic leukemia
Pediatric blood & cancer 60 (2), 293-300, 2013
View on Google Scholar ↗
2013 82 71.3%
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma
Nature communications 12 (1), 4089, 2021
View on Google Scholar ↗
2021 29 71.1%
CD58 aberrations limit durable responses to CD19 CAR in large B cell lymphoma patients treated with axicabtagene ciloleucel but can be overcome through novel CAR engineering
Blood 136, 53-54, 2020
View on Google Scholar ↗
2020 38 70.2%
Neuronal activity in the glioma microenvironment
Current opinion in neurobiology 47, 156-161, 2017
View on Google Scholar ↗
2017 58 69.4%
Human pontine glioma cells can induce murine tumors
Acta neuropathologica 127, 897-909, 2014
View on Google Scholar ↗
2014 71 69.1%
Characteristics of patients≥ 10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry
Neuro-oncology 24 (1), 141-152, 2022
View on Google Scholar ↗
2022 16 68.0%
Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma
Journal of neuro-oncology 117, 175-182, 2014
View on Google Scholar ↗
2014 68 68.0%
A protocol for rapid post-mortem cell culture of diffuse intrinsic pontine glioma (DIPG)
JoVE (Journal of Visualized Experiments), e55360, 2017
View on Google Scholar ↗
2017 54 67.6%
Adaptive and maladaptive myelination in health and disease
Nature Reviews Neurology 18 (12), 735-746, 2022
View on Google Scholar ↗
2022 15 66.5%
MRI-based radiomics for prognosis of pediatric diffuse intrinsic pontine glioma: an international study
Neuro-oncology advances 3 (1), vdab042, 2021
View on Google Scholar ↗
2021 23 65.2%
Synaptic communication in brain cancer
Cancer research 80 (14), 2979-2982, 2020
View on Google Scholar ↗
2020 31 65.1%
H3-K27M-mutant nucleosomes interact with MLL1 to shape the glioma epigenetic landscape
Cell Reports 39 (7), 2022
View on Google Scholar ↗
2022 14 64.7%
Kinase-modulated bioluminescent indicators enable noninvasive imaging of drug activity in the brain
ACS Central Science 9 (4), 719-732, 2023
View on Google Scholar ↗
2023 8 64.5%
Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas
Journal of neuro-oncology 108, 395-402, 2012
View on Google Scholar ↗
2012 65 64.4%
TERT and DNMT1 expression predict sensitivity to decitabine in gliomas
Neuro-oncology 23 (1), 76-87, 2021
View on Google Scholar ↗
2021 22 64.0%
International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma
Journal of neuro-oncology 141, 253-263, 2019
View on Google Scholar ↗
2019 35 63.7%
Effect of cancer therapy on neural stem cells: implications for cognitive function
Current opinion in oncology 24 (6), 672, 2012
View on Google Scholar ↗
2012 59 61.9%
Emerging mechanistic underpinnings and therapeutic targets for chemotherapy-related cognitive impairment
Current opinion in oncology 31 (6), 531, 2019
View on Google Scholar ↗
2019 32 61.3%
Microenvironmental interactions of oligodendroglial cells
Developmental cell 56 (13), 1821-1832, 2021
View on Google Scholar ↗
2021 18 58.6%
Neural signaling in cancer
Annual review of neuroscience 45, 199-221, 2022
View on Google Scholar ↗
2022 11 58.2%
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities
Cancer cell 41 (4), 660-677. e7, 2023
View on Google Scholar ↗
2023 6 57.4%
The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease
Journal of neuro-oncology 132 (2), 323-331, 2017
View on Google Scholar ↗
2017 34 55.8%
Glioblastoma remodeling of neural circuits in the human brain decreases survival
BioRxiv, 2021.02. 18.431915, 2021
View on Google Scholar ↗
2021 16 55.4%
Free radicals are involved in the damage to protein synthesis after anoxia/aglycemia and NMDA exposure
Brain research 857 (1-2), 172-182, 2000
View on Google Scholar ↗
2000 45 53.3%
Prevention of deficits in neurogenesis with anti-inflammatory agents
US Patent App. 10/826,472, 2004
View on Google Scholar ↗
2004 42 51.5%
Brain perfusion and diffusion abnormalities in children treated for posterior fossa brain tumors
The Journal of Pediatrics 185, 173-180. e3, 2017
View on Google Scholar ↗
2017 28 50.8%
Settling a nervous stomach: the neural regulation of enteric cancer
Cancer Cell 31 (1), 1-2, 2017
View on Google Scholar ↗
2017 27 49.9%
Neuron–Glial Interactions in Health and Brain Cancer
Advanced biology 6 (9), 2200122, 2022
View on Google Scholar ↗
2022 8 49.6%
The neural regulation of cancer
Annual Review of Cancer Biology 4, 371-390, 2020
View on Google Scholar ↗
2020 16 47.5%
Neuronal-activity dependent mechanisms of small cell lung cancer progression
bioRxiv, 2023.01. 19.524430, 2023
View on Google Scholar ↗
2023 4 47.4%
The bright and the dark side of myelin plasticity: neuron-glial interactions in health and disease
Seminars in cell & developmental biology 116, 10-15, 2021
View on Google Scholar ↗
2021 12 47.4%
DIPG-10. A Phase I trial of panobinostat following radiation therapy in children with diffuse intrinsic pontine glioma (DIPG) or H3K27M-mutated thalamic diffuse midline glioma (DMG): Report from the Pediatric Brain Tumor Consortium (PBTC-047)
Neuro-Oncology 24 (Supplement_1), i19-i20, 2022
View on Google Scholar ↗
2022 7 46.0%
Pediatric brain tumors
CONTINUUM: Lifelong Learning in Neurology 26 (6), 1553-1583, 2020
View on Google Scholar ↗
2020 15 45.8%
Neurological complications following treatment of children with brain tumors
Journal of pediatric rehabilitation medicine 4 (1), 31-36, 2011
View on Google Scholar ↗
2011 29 45.4%
Hedgehogs, flies, Wnts and MYCs: the time has come for many things in medulloblastoma
J Clin Oncol 29 (11), 1395-8, 2011
View on Google Scholar ↗
2011 29 45.4%
Calbindin overexpression buffers hippocampal cultures from the energetic impairments caused by glutamate
Brain research 911 (1), 37-42, 2001
View on Google Scholar ↗
2001 26 44.1%
Partitioned glioma heritability shows subtype-specific enrichment in immune cells
Neuro-oncology 23 (8), 1304-1314, 2021
View on Google Scholar ↗
2021 10 42.5%
A comparative study of brain tumor cells from different age and anatomical locations using 3D biomimetic hydrogels
Acta biomaterialia 116, 201-208, 2020
View on Google Scholar ↗
2020 13 42.2%
Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)
Neuro-oncology 25 (12), 2262-2272, 2023
View on Google Scholar ↗
2023 3 40.7%
Spinal cord injury—healing from within
New England Journal of Medicine 384 (2), 182-184, 2021
View on Google Scholar ↗
2021 9 39.8%
Inhibiting USP16 rescues stem cell aging and memory in an Alzheimer’s model
Elife 11, e66037, 2022
View on Google Scholar ↗
2022 5 37.6%
NCI-CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors—Histone Mutated Midline Glioma Workshop Proceedings
Neuro-Oncology Advances 2 (1), vdaa007, 2020
View on Google Scholar ↗
2020 10 36.0%
Dipg-22. A phase 1 trial of the histone deacetylase inhibitor panobinostat in pediatric patients with recurrent or refractory diffuse intrinsic pontine glioma: A pediatric brain tumor consortium (pbtc) study
Neuro-Oncology 20 (Suppl 2), i53, 2018
View on Google Scholar ↗
2018 13 35.3%
Gene therapy effectiveness differs for neuronal survival and behavioral performance
Gene therapy 8 (8), 579-585, 2001
View on Google Scholar ↗
2001 13 33.8%
Durable response of a radiation-induced, high-grade cerebellar glioma to temozolomide
Journal of neuro-oncology 84, 179-183, 2007
View on Google Scholar ↗
2007 14 32.9%
A light-gated transcriptional recorder for detecting cell-cell contacts
Elife 11, e70881, 2022
View on Google Scholar ↗
2022 4 32.5%
GABAergic neuron-to-glioma synapses in diffuse midline gliomas
bioRxiv, 2022.11. 08.515720, 2022
View on Google Scholar ↗
2022 4 32.5%
Unravelling the mechanisms of cancer-related cognitive dysfunction in non–central nervous system cancer
JAMA oncology 7 (9), 1311-1312, 2021
View on Google Scholar ↗
2021 6 30.5%
Abstract CT031: GD2 CAR T cells mediate clinical activity and manageable toxicity in children and young adults with DIPG and H3K27M-mutated diffuse midline gliomas
Cancer Research 81 (13_Supplement), CT031-CT031, 2021
View on Google Scholar ↗
2021 5 26.8%
Epct-14. GD2 Car T-Cells Mediate Clinical Activity and Manageable Toxicity in Children and Young Adults with H3k27m-Mutated Dipg and Spinal Cord DMG
Neuro-Oncology 23 (Supplement_1), i49-i50, 2021
View on Google Scholar ↗
2021 5 26.8%
Open questions: why are babies rarely born with cancer?
BMC biology 16, 1-2, 2018
View on Google Scholar ↗
2018 8 26.7%
Abstract CT001: Major tumor regressions in H3K27M-mutated diffuse midline glioma (DMG) following sequential intravenous (IV) and intracerebroventricular (ICV) delivery of GD2-CAR T cells
Cancer Research 82 (12_Supplement), CT001-CT001, 2022
View on Google Scholar ↗
2022 3 26.5%
Understanding the deadly silence of posterior fossa A ependymoma
Molecular cell 78 (6), 999-1001, 2020
View on Google Scholar ↗
2020 6 25.9%
Dipg-03. Targeting pi3k using the blood brain barrier penetrable inhibitor, gdc-0084, for the treatment of diffuse intrinsic pontine glioma (dipg)
Neuro-oncology 21 (Supplement_2), ii68-ii68, 2019
View on Google Scholar ↗
2019 6 24.3%
Mini-review: Aplastic myelin following chemotherapy
Neuroscience Letters, 136861, 2022
View on Google Scholar ↗
2022 2 19.7%
Invasive glioma cells: The malignant pioneers that follow the current
Cell 185 (16), 2846-2848, 2022
View on Google Scholar ↗
2022 2 19.7%
Maladaptive myelination promotes epileptogenesis in absence epilepsy
bioRxiv, 2020.08. 20.260083, 2020
View on Google Scholar ↗
2020 4 19.6%
Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas
Cell Reports Medicine 4 (6), 2023
View on Google Scholar ↗
2023 1 19.5%
Multifocal demyelinating leukoencephalopathy and oligodendroglial lineage cell loss with immune effector cell-associated neurotoxicity syndrome (ICANS) following CD19 CAR T-cell therapy for mantle cell lymphoma
Journal of Neuropathology & Experimental Neurology 82 (2), 160-168, 2023
View on Google Scholar ↗
2023 1 19.5%
CAR T cell therapies for diffuse midline glioma
Trends in cancer, 2023
View on Google Scholar ↗
2023 1 19.5%
Engineered CD47 protects T cells for enhanced antitumor immunity
bioRxiv, 2023.06. 20.545790, 2023
View on Google Scholar ↗
2023 1 19.5%
Clinically relevant concurrent BRAF and MEK inhibition alters differentiation states and sensitizes BRAF V600E-mutated high-grade gliomas to immune checkpoint blockade
bioRxiv, 2023.02. 03.526065, 2023
View on Google Scholar ↗
2023 1 19.5%
Chemoradiation impairs normal developmental cortical thinning in medulloblastoma
Journal of Neuro-oncology 133, 429-434, 2017
View on Google Scholar ↗
2017 5 19.4%
Omic-11. Single cell RNA sequencing from the csf of subjects with h3k27m+ dipg/dmg treated with gd2 car t-cellular therapy
Neuro-oncology 23 (Supplement_1), i39-i39, 2021
View on Google Scholar ↗
2021 3 18.6%
nan
2018
View on Google Scholar ↗
2018 4 17.5%
Neurological complications of oncological therapy
Handbook of neuro-oncology neuroimaging, 102-115, 2008
View on Google Scholar ↗
2008 4 17.5%
Complete ocular paresis in a child with posterior fossa syndrome
Pediatric Neurosurgery 48 (1), 51-54, 2012
View on Google Scholar ↗
2012 4 16.6%
Novel orthotopic pediatric high grade glioma xenografts evaluated with magnetic resonance imaging mimic human disease
Cancer Research 75 (15_Supplement), 3271-3271, 2015
View on Google Scholar ↗
2015 4 16.3%
Neurologic Complications of Oncologic Therapy
Handbook of Neuro-Oncology Neuroimaging, 125-142, 2016
View on Google Scholar ↗
2016 4 16.3%
Drug screening linked to molecular profiling identifies novel dependencies in patient-derived primary cultures of paediatric high grade glioma and DIPG
bioRxiv, 2020.12. 29.424674, 2020
View on Google Scholar ↗
2020 3 16.2%
Neurological complications in adults
Late effects of treatment for brain tumors, 113-132, 2009
View on Google Scholar ↗
2009 3 15.1%
Immu-19. LSD1 modulates nk cell immunotherapy through an onco-immunogenic gene signature in dipg
Neuro-Oncology 20 (Suppl 2), i102, 2018
View on Google Scholar ↗
2018 3 14.6%
Psychiatric symptoms in children with medulloblastoma
Neuro-Oncology 14, 128-128, 2012
View on Google Scholar ↗
2012 3 13.9%
GD2 CAR T cells mediate clinical activity and manageable toxicity in children and young adults with DIPG and H3K27M-mutated diffuse midline gliomas.
CANCER RESEARCH 81 (13), 2021
View on Google Scholar ↗
2021 2 13.8%
BIOL-05. MAPK PATHWAY INHIBITION SENSITIZES TO IMMUNOTHERAPY IN BRAF-MUTANT GLIOMAS
Neuro-Oncology 23 (Suppl 1), i3, 2021
View on Google Scholar ↗
2021 2 13.8%
DIPG-29. Phosphatidylinositol-4, 5-bisphosphate 3-kinase (PI3K) inhibition drives protein kinase c activation (PKC) in diffuse intrinsic pontine glioma (DIPG)
Neuro-oncology 22 (Supplement_3), iii292-iii293, 2020
View on Google Scholar ↗
2020 2 12.1%
Bespoke myelin tailored to neuron type
Science 370 (6523), 1414-1415, 2020
View on Google Scholar ↗
2020 2 12.1%
Treating cancer therapy–related cognitive impairment
Nature Medicine 26 (8), 1174-1175, 2020
View on Google Scholar ↗
2020 2 12.1%
Glioma-Neuronal Interactions: A Study of Tumor Integration and Synaptogenesis Mediated Language Plasticity in Adult High-Grade Glioma
Neurosurgery 67, 2020
View on Google Scholar ↗
2020 2 12.1%
Inflaming glioma growth
Neuro-oncology 21 (10), 1213-1214, 2019
View on Google Scholar ↗
2019 2 12.0%
Inhibition of hippocampal neurogenesis in humans after treatment for central nervous system malignancies
NEUROLOGY 68 (12), A289-A289, 2007
View on Google Scholar ↗
2007 2 11.3%
Myelin plasticity in ventral tegmental area is required for opioid reward
bioRxiv, 2022.09. 01.506263, 2022
View on Google Scholar ↗
2022 1 11.3%
DDDR-25. CO-INHIBITION OF KINASE SIGNALING PATHWAYS AND EPIGENETIC REGULATORS OVERCOMES COMPENSATORY EFFECTS IN PEDIATRIC HIGH-GRADE GLIOMAS
Neuro-Oncology 24 (Suppl 7), vii104, 2022
View on Google Scholar ↗
2022 1 11.3%
Meditation, Mäuse und Myelin
Nervenheilkunde 37 (10), 745-748, 2018
View on Google Scholar ↗
2018 2 11.3%
Targeting neuronal activity-regulated neuroligin-3 dependency for high-grade glioma therapy
bioRxiv, 153122, 2017
View on Google Scholar ↗
2017 2 11.1%
TAMI-69. NF1 MUTATION DRIVES NEURONAL ACTIVITY-DEPENDENT OPTIC GLIOMA INITIATION
Neuro-Oncology 23 (Suppl 6), vi212, 2021
View on Google Scholar ↗
2021 1 8.0%
HGG-05. Neuronal Activity Promotes Pediatric High-Grade Glioma Growth Through A Nlgn3-Cspg4 Signaling Axis
Neuro-oncology, 2021
View on Google Scholar ↗
2021 1 8.0%
BSTM-04. NEURONAL-ACTIVITY SECRETED BDNF INCREASES DIPG PROLIFERATION.
Neuro-Oncology 21 (Suppl 2), ii67, 2019
View on Google Scholar ↗
2019 1 7.2%
Patient-Derived Orthotopic Xenografts and Cell Lines from Pediatric High-Grade Glioma Recapitulate the Heterogeneity of Histopathology, Molecular Signatures, and Drug Response
bioRxiv, 2020.12. 06.407973, 2020
View on Google Scholar ↗
2020 1 7.1%
Cranial radiation therapy and damage to hippocampal neurogenesis, ev
Disabil Res Rev 14 (3), 1238-1242, 2008
View on Google Scholar ↗
2008 1 6.8%
Dipg-41. Identification of Birc5 as a Novel Therapeutic Target for Diffuse Intrinsic Pontine Glioma
Neuro-Oncology 20 (Suppl 2), i57, 2018
View on Google Scholar ↗
2018 1 6.8%
Anti-GD2 chimeric antigen receptor T cells as a potent immunotherapy regimen in xenograft models of histone 3 K27M mutant diffuse midline glioma
Cancer Research 78 (13_Supplement), 958-958, 2018
View on Google Scholar ↗
2018 1 6.8%
DIPG-29. Genomic landscape of diffuse intrinsic pontine glioma: an analysis of the DIPG-BATs cohort
Neuro-oncology 19 (suppl_4), iv11-iv11, 2017
View on Google Scholar ↗
2017 1 6.6%
Recurrent Activating Acvr1/Alk2 Mutations in Diffuse Intrinsic Pontine Glioma
Neuro-Oncology 15, 174-175, 2013
View on Google Scholar ↗
2013 1 6.6%
Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain
Glia 63, E17-E18, 2015
View on Google Scholar ↗
2015 1 6.3%
HG-04NEURONAL activity-regulated secretion of neuroligin-3 promotes glioma growth
Neuro-Oncology 17 (Suppl 3), iii11, 2015
View on Google Scholar ↗
2015 1 6.3%
HG-78SYNTHETIC LETHAL EPIGENETIC INTERACTIONS IN K27M MUTATED DIPG
Neuro-oncology 18 (Suppl 3), iii66, 2016
View on Google Scholar ↗
2016 1 6.3%
HG-99 A PATIENT-DERIVED PAEDIATRIC HIGH GRADE GLIOMA AND DIPG CELL CULTURE PANEL RECAPITULATING THE GENOTYPIC AND PHENOTYPIC DIVERSITY OF THE DISEASE
Neuro-oncology 18 (suppl_3), iii71-iii71, 2016
View on Google Scholar ↗
2016 1 6.3%
Neural Stem Cells and the Effects of Cancer Therapy
Neural Stem Cells in Health and Disease, 97-131, 2016
View on Google Scholar ↗
2016 1 6.3%
ME-08NEURONS PROMOTE GLIOMA GROWTH IN AN ACTIVITY-DEPENDENT MANNER
Neuro-Oncology 16 (Suppl 5), v121, 2014
View on Google Scholar ↗
2014 1 6.3%
Differential sensitivity of oligodendrocyte precursor cells and microglia to methotrexate in grey versus white matter (P7. 011)
Neurology 82 (10 Supplement), 2014
View on Google Scholar ↗
2014 1 6.3%
Psychiatric symptoms in survivors of childhood germ cell tumors
NEURO-ONCOLOGY 14, 50-50, 2012
View on Google Scholar ↗
2012 1 6.2%